The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.68
Bid: 42.72
Ask: 42.84
Change: 1.06 (2.55%)
Spread: 0.12 (0.281%)
Open: 42.28
High: 42.84
Low: 42.12
Prev. Close: 41.62
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Jul 2016 07:00

RNS Number : 4948E
Assura PLC
19 July 2016
 

19 July 2016

 

Assura plc

 

Trading Update

For the first quarter to 30 June 2016

 

Continued strong growth

 

Assura plc ("Assura"), the UK's leading primary care property investor and developer, today publishes a trading update for the first quarter to 30 June 2016.

 

Value enhancing investment activity

 

Assura continued to make good progress in the first quarter, completing the acquisition of 30 medical centres for a gross consideration of £65.4 million with a passing rent roll of £4.1 million and a weighted average unexpired lease length of 14.1 years.

 

Assura has a further pipeline of individual asset acquisitions and developments currently in solicitors' hands worth £105 million.

 

Rental income increased

 

Assura now owns 351 medical centres with a total annualised rent roll of £68.4 million (31 March 2016: £63.8 million), with growth in the financial year to date driven primarily by acquisitions. In addition, we are maximising income through active asset management: the letting of vacant space has been a particular focus in the first quarter with £0.3 million in new lettings secured in the period.

 

The weighted average annual rent increase was 1.43% on the basis of 32 reviews settled in the quarter, of which open market rents reviews were 1.30%.

 

Strong financing and debt position

 

On 18 May 2016 we secured a new £200 million revolving credit facility on an unsecured basis to replace the existing facility. The initial margin is 150 basis points, which is a reduction of 20 basis points from the previous facility, and the facility increases operational flexibility and reduces transaction costs associated with financing properties. Undrawn facilities currently stand in excess of £115 million.

 

At 30 June 2016, Assura's loans stood at £411.9m, with a weighted average cost of debt of 4.55% (31 March 2016: 4.84%) and a weighted average debt maturity of 10.2 years. At the same date, Assura's proforma net loan to value ratio was 33% (31 March 2016: 30%).

 

Market background

 

We have seen no direct impact to date from the recent EU referendum, although we realise that the result may create political and economic uncertainty, which could affect investment in primary care infrastructure. However, the need for investment in primary care premises is recognised by the NHS as a priority, as more services are being provided by the primary care sector and there is also an increasing need to meet the health needs of a growing and ageing population.

 

 

Simon Laffin, Executive Chairman, commented:

 

"We have had another active quarter as we continue our strong growth. Our greater financial flexibility positions us well, while our investment strategy is continuing to generate value. Assura is increasingly well positioned to help the NHS develop the modern and effective primary care infrastructure that is so necessary for this country."

 

- Ends -

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Simon Laffin

Jonathan Murphy

 

 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson

 

 

Notes to Editors

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2016, Assura's property portfolio was valued at £1,111 million.

 

Further information is available at www.assuraplc.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVSDEITLIR
Date   Source Headline
22nd Dec 20167:00 amRNSScrip Calculation Price
8th Dec 20167:00 amRNSNotice of Dividend
22nd Nov 20167:00 amRNSInterim Results 2016
1st Nov 20167:00 amRNSTotal Voting Rights
21st Oct 20162:37 pmRNSNotification of Major Interest in Shares
19th Oct 20169:00 amRNSNotification of Transaction by PDMR
17th Oct 20167:00 amRNSScrip Dividend Declaration
3rd Oct 20167:00 amRNSAppointment of Interim CEO and director
3rd Oct 20167:00 amRNSTrading Update
22nd Sep 20167:00 amRNSScrip Calculation Price
20th Sep 20165:14 pmRNSNotification of Major Interest in Shares
16th Sep 20163:35 pmRNSNotification of Major Interest in Shares
13th Sep 201611:05 amRNSNotification of transactions by PDMRs
8th Sep 20167:00 amRNSNotice of Dividend
1st Sep 20168:00 amRNSTotal Voting Rights
31st Aug 20164:49 pmRNSExercise of Nil Cost Options under VCP
26th Aug 201611:00 amRNSAdditional Listing
9th Aug 20168:00 amRNSDirector/PDMR Shareholdings
1st Aug 20168:00 amRNSTotal Voting Rights
29th Jul 201611:44 amRNSAnnual Information Update
27th Jul 20168:00 amRNSDirector/PDMR Shareholdings
25th Jul 20168:00 amRNSScrip Dividend Declaration
19th Jul 20164:40 pmRNSResult of AGM
19th Jul 20167:00 amRNSTrading Update
4th Jul 201611:34 amRNSGraham Roberts
30th Jun 20167:00 amRNSScrip Calculation Price
17th Jun 20169:11 amRNSPayment on cessation of directorship
16th Jun 20169:00 amRNSNotice of Dividend
15th Jun 20164:16 pmRNSAnnual Report & Notice of AGM
14th Jun 20167:00 amRNSUpdate statement regarding Graham Roberts
23rd May 20163:48 pmRNSDirector/PDMR Shareholding
18th May 20167:00 amRNSFull Year Results
6th May 20169:34 amRNSNotification of Major Interest in Shares
4th May 20169:01 amRNSTotal Voting Rights
26th Apr 201612:24 pmRNSNotification of Major Interest in Shares
20th Apr 201612:28 pmRNSNotification of Major Interest in Shares
20th Apr 20167:00 amRNSDirector/PDMR Shareholdings
18th Apr 20167:00 amRNSScrip Dividend Declaration
24th Mar 20164:25 pmRNSNotification of Major Interest in Shares
24th Mar 201612:22 pmRNSScrip calculation price
22nd Mar 20166:05 pmRNSDirector/PDMR Shareholding
22nd Mar 20163:56 pmRNSNotification of Major Interest in Shares
21st Mar 20167:00 amRNSDirector/PDMR Shareholding
15th Mar 201611:54 amRNSDirector/PDMR Shareholding
10th Mar 20167:00 amRNSNotice of Dividend
4th Mar 20167:00 amRNSFurther statement regarding Graham Roberts
29th Feb 20167:00 amRNSDirector Declaration
9th Feb 20167:05 amRNSTrading Update
9th Feb 20167:00 amRNSStatement regarding Chief Executive Graham Roberts
1st Feb 20167:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.